Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
|
T.LABS.W.B
Healthcare
Drug Manufacturers - Specialty & Generic
Cannabis
MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative...
products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(61)
•••
subaru1i
X
Post by
subaru1i
on Jun 03, 2023 9:28pm
LABS - Epidiolex deal IS already structured and pending
release. Pay attention please: CEO David Pidduck made this statement already twice or the second time might have been by the CFO...."it will change the face of the company"
...more
(61)
•••
subaru1i
X
Post by
subaru1i
on Jun 03, 2023 12:04pm
THC reduce obesity, hence increases health and reduces risk
of obesity related diseases such as diabetes, etc, etc,. Post retirement, from 245 lbs down to 198 pounds, feeling more energetic and with no more knee joint pain. I cannot imagine now
...more
(61)
•••
subaru1i
X
Comment by
subaru1i
on Jun 03, 2023 11:56am
RE:RE:RE:RE:"Global pharmaceutical partner" = exclusivity
You cannot replace unknown variables with hope, only the passage of time will provide solutions to the unknown variables. For example, 2+2=? 5x6=? 10/2=? what provides
...more
(16)
•••
rejaj
X
Comment by
rejaj
on Jun 03, 2023 10:49am
RE:RE:RE:"Global pharmaceutical partner" = exclusivity
subaru1i, there is an aspect of hope that does have some relevance in the execution of a business strategy and when investing in general. As you note, having all the important inputs and factors
...more
(61)
•••
subaru1i
X
Post by
subaru1i
on Jun 02, 2023 6:10pm
Apotex and China?
FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage Qilu Pharmaceutical, which makes and markets cisplatin injections in China, received FDA permission to export the
...more
•••
Jon Brown
X
Post by
Jon Brown
on Jun 02, 2023 4:20pm
@ the Bell: Markets come roaring back
After a few lacklustre sessions, Canada's main stock index joined markets across the globe in a higher trading day on Friday
read article.
(61)
•••
subaru1i
X
Post by
subaru1i
on Jun 02, 2023 12:25pm
LABS in conjunction with McMaster University (Degroote
School of Medicine) currently have research/clinical trial within this scope. Keep in mind, the disease is an 'autoimmune' system disease and the immune system responds to
...more
•••
Jon Brown
X
Post by
Jon Brown
on Jun 01, 2023 4:18pm
@ the Bell: Markets firm following debt ceiling deal
Equities in Canada’s largest edged up on Thursday, all over a pause in US rate hikes and the passing of a bill to suspend the debt ceiling.
read article.
(61)
•••
subaru1i
X
Comment by
subaru1i
on Jun 01, 2023 3:38pm
RE:RE:RE:Risk/Reward analysis, fact based not emotionally driven
That is a very conservative strategy especially when applied to a young investor that has a longer lifespan and therefore is capable of assuming a little more risk in their portfolio so a good
...more
(83)
•••
Starkicker
X
Comment by
Starkicker
on Jun 01, 2023 3:32pm
RE:RE:Risk/Reward analysis, fact based not emotionally driven
If I had an MBA I would tell young imvestors to buy blue chip stocks with dividends and sit back and relax instead of screwing around with these drama-filled venture exchange head cases.
(61)
•••
subaru1i
X
Comment by
subaru1i
on Jun 01, 2023 11:29am
RE:Risk/Reward analysis, fact based not emotionally driven
In summary, I really don't care what the stock price is currently doing relative to the facts because with or without a business degree or MBA, everybody should know that "money talks and
...more
(61)
•••
subaru1i
X
Post by
subaru1i
on Jun 01, 2023 11:24am
Risk/Reward analysis, fact based not emotionally driven
So a logic centric investor should be able to evaluate, retail or institutional, am I willing to buy LABS stock at the existing price and take a small risk relative to a very large reward on the
...more
(61)
•••
subaru1i
X
Post by
subaru1i
on Jun 01, 2023 10:46am
LABS future stock price with an Epidiolex exclusive using
valuation model of Pf=EPS x P/E where Pf is future stock price, EPS is earnings per share driven LABS profit margin multiplied by sales and divided by number of shares outstanding. P/E ratio is
...more
•••
Jon Brown
X
Post by
Jon Brown
on Jun 01, 2023 9:00am
Buzz on the Bullboards: Can health care and energy stocks help “recession proof” your portfolio?
Investors often keep focused on the most consistent plays, when times of renewed uncertainty rears its head in the markets.
read article.
(61)
•••
subaru1i
X
Comment by
subaru1i
on May 31, 2023 11:58am
RE:RE:"Global pharmaceutical partner" = exclusivity
"hope" is purely an emotional emmulation of thought with no application in the logic of conducting and executing a business strategy.
(40)
•••
subaru1
X
Comment by
subaru1
on May 31, 2023 11:48am
RE:"Global pharmaceutical partner" = exclusivity
I hope you are right..
(61)
•••
subaru1i
X
Post by
subaru1i
on May 31, 2023 11:00am
"Global pharmaceutical partner" = exclusivity
"patent THREATS" X=Epidiolex Y= business competitor(s) posing the THREAT IF X is under threat by Y THEN X is the target 'raise the bar' 'change the playing field' '
...more
(61)
•••
subaru1i
X
Post by
subaru1i
on May 31, 2023 1:29am
LABS mentioned 'patent threats' in the more recent past and
seeing what they have done so far via the FDA, those actions could easily be applied to JAZZ Pharma obtaining an FDA approved but YET very unique CBD formulation that would be used in Epidiolex with
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Canada Nickel Continues to Intersect High-grade, Near-surface Mineralization at Texmont Project
Noble Mineral Exploration to Acquire a Mining Claim in Newfoundland Covering Approximately 175 Hectares
DehydraTECH Licensing Revenues increases 5x and Hits Another Quarterly Record with New Licensees
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report
Q2 Metals Initiates Phase Two of Exploration Work at Its Mia Lithium Property in James Bay, Quebec